Episode
They Deleted Texts, Blocked the Inquiry TWICE – Now EU MEPs Sue to Uncover the Pfizer Scandal
- Podcast
- Rand Radio
- Published
- Jan 27, 2026
- Duration seconds
- 123
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/rand-radio-7193419/episodes/they-deleted-texts-blocked-the-inquiry-twice-now-eu-meps-sue-to-uncover-the-pfizer-scandal/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/rand-radio-7193419/they-deleted-texts-blocked-the-inquiry-twice-now-eu-meps-sue-to-uncover-the-pfizer-scandal.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
The EU rushed the purchase of more than €35 billion Pfizer-BioNTech mRNA vaccines in 2020–2021, the largest in history. If you think that’s a lot of money, you’re mistaken. With strong-willed Europeans going to bat for their people, there’s going to be hell to pay. German Member of Parliament, Christine Anderson, recently stood before the world in Brussels and shook the European Parliament. Ursula von der Leyen contributed €35 billion to Pfizer mRNA contracts and she wants to know why. She also tried to hide her contribution. Von der Leyen personally negotiated with Bourla , bypassing standard, lawful procedures. Did she know all along what she was really doing with that big of a chunk of change? Ursula Gertrud von der Leyen is a German politician, physician, and the first woman to serve as President of the European Commission since July 2019. She was re-elected to a second term in 2024, overseeing the EU’s executive branch, which enforces laws, manages budgets, and drives policies on trade, climate, and health for 450 million citizens across 27 member states. Her background is in medicine and economics. She’s seemingly blending the World Health Organization (WHO) and World Economic Forum (WEF) models of using people for financial gain while slowly killing them. It’s been lucrative for them thus far. For direct profits from the “pandemic” alone, not including additional windfalls that would be made due to cancer drugs, Alzheimer’s drugs, drugs for heart disease, etc. Companies like Pfizer, BioNTech, Moderna, AstraZeneca, Johnson & Johnson, and others all had global sales peaks in 2021–2022 before boosters started to decline because word got out that their shots were killing people: A rough, if not modest, estimate is that they made between $180 and $200 billion . A lik…